# Screening Diabetes Patients for NAFLD With Controlled Attenuation Parameter and Liver Stiffness Measurements

> **NCT03060694** · — · COMPLETED · sponsor: **Xinhua Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 58 (actual)

## Conditions studied

- Non-alcoholic Fatty Liver Disease

## Interventions

- **OTHER:** diabetes

## Key facts

- **NCT ID:** NCT03060694
- **Lead sponsor:** Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2017-02
- **Final completion:** 2017-05
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2018-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03060694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03060694, "Screening Diabetes Patients for NAFLD With Controlled Attenuation Parameter and Liver Stiffness Measurements". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03060694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*